que es mejor la semaglutida o la tirzepatide Tirzepatida vs Semaglutida. Diferencias y alternativas TIRZEPATIDA vs SEMAGLUTIDA (¿Quién gana

Wegovy is also FDA-approved for cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight, and for chronic weight management in pediatric patients aged 12 years and older with obesity

Many people with obesity carry HOMA-IR values of 3.0 to 6.0 while still maintaining "normal" fasting glucose through compensatory hyperinsulinemia

Infiltracin lipdica de hgado y msculo (hgado graso, coma heptico, cirrosis heptica, hepatomegalia, encefalopata heptica)

However, more research is needed in this area

Any potential benefits described are based on preliminary research and clinical observations and may not be supported by large-scale, long-term studies